National CLABSI Project Reduced ICU Infection Rate 41%
AHRQ released a final report on the national On the CUSP: Stop BSI project, which began in 2008 and was funded by AHRQ. The initiative was led by a partnership of the Health Research & Educational Trust of the American Hospital Association, the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality and the Michigan Health & Hospital Association's Keystone Center for Patient Safety & Quality — together forming the National Project Team. The National Project Team provided education, data collection and program management to participating states.
A total of 44 states the District of Columbia, and Puerto Rico participated in the two-year program, bringing more than 1,000 hospitals and 1,800 hospital units. States could join the program in 2009, 2010 or 2011.
Through On the CUSP: Stop BSI, states reduced their adult ICU CLABSI rate from 1.915 infections per 1,000 line days to 1.133 infections — a decrease of 41 percent. In addition, by quarter six, the percentage of units with zero CLABSIs for at least one quarter reached 68 percent from a baseline of 30 percent.
These improvements are estimated to have averted 290 to 605 deaths and $36,194,850 to $40,034,450 in excess costs, based on a Centers for Disease Control & Prevention estimate of the cost per CLABSI. However, a systematic review of the cost of CLABSI indicated the cost may be higher, which would increase the savings from the project to $97,756,628 to $244,270,620, according to the report.
More Articles on the On the CUSP Project:Patient Safety Tool: CLABSI Toolkit
Patient Safety Tool: Physician Engagement Self-Diagnostic Worksheet
National Patient Safety Project Reduced CLABSI by 40%
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- UnitedHealthcare now posts Healthgrades star ratings for each physician: 7 key notes
- Joint Commission: New tools for medical error prevention
- Mederi Therapeutics launches 3rd generation of Stretta, Boston Scientific reports Q1 2016 financials & more — 5 GI company key notes
- Gastroenterologist pay in the US, UK, Canada & Australia: 5 notes
- Seres Therapeutics signs research agreements to support development of microbiome therapy for IBD: 3 points